C Partners Holding’s Pfizer PFE Stock Holding History

C Partners Holding’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Buy	+1,200	New	+$31.4K	0.06%	15

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

C Partners Holding's PFE Position: Q4 2018 in Review

C Partners Holding sold out of Pfizer (PFE) in Q4 2018, closing a stake of 3,181 shares — an estimated $133K sold.

C Partners Holding first reported a position in PFE in Q4 2014 and held it in 7 quarters. The position peaked at $1.74M in Q1 2015. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

C Partners Holding reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
C Partners Holding sold 3,181 Pfizer shares in Q4 2018, an estimated $133K.
C Partners Holding first reported a position in Pfizer in Q4 2014 and held it in 7 quarters.
C Partners Holding's Pfizer position peaked at $1.74M in Q1 2015.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.